1 December 2025 - The December 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are a few major listings of note this month.

• Faricimab (Vabysmo) - new medicine
• Entrectinib (Rozlytek) - new medicine
• Ocrelizumab with hyaluronidase (human, recombinant) (Ocrevus SC) - new formulation
• Pertuzumab with trastuzumab and hyaluronidase (human, recombinant) (Phesgo) - new combination product

Read New Zealand Pharmaceutical Schedule update